Protagonist Therapeutics (PTGX) PT Lowered to $41 at BTIG
Tweet
Share
E-mailGet Alerts PTGX Hot Sheet
Price: $155.10 --0%
Rating Summary:
20 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 13
Rating Summary:
20 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 13
Join SI Premium – FREE
BTIG analyst Julian Harrison lowered the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $41.00 (from $45.00) while maintaining a Buy rating.
You May Also Be Interested In
- JD.com, Inc (JD) PT Lowered to $30 at Susquehanna
- NKT A/S (NKT:DC) PT Raised to DKK917 at JPMorgan
- Deutsche Bank Downgrades Netskope (NTSK) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
